Wasatch Advisors’s Juno Therapeutics, Inc. JUNO Stock Holding History

Wasatch Advisors’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-629,636	Closed	-$28.8M	–	318
2017 Q4	$28.8M	Sell	629,636 -21,380	-3%	-$1.07M	0.38%	73
2017 Q3	$29.2M	Sell	651,016 -10,982	-2%	-$374K	0.4%	75
2017 Q2	$19.8M	Buy	+661,998	New	+$16.3M	0.28%	82

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wasatch Advisors's JUNO Position: Q1 2018 in Review

Wasatch Advisors sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 629,636 shares — an estimated $28.8M sold.

Wasatch Advisors first reported a position in JUNO in Q2 2017 and held it in 3 quarters. The position peaked at $29.2M in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Wasatch Advisors reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Wasatch Advisors sold 629,636 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $28.8M.
Wasatch Advisors first reported a position in Juno Therapeutics, Inc. in Q2 2017 and held it in 3 quarters.
Wasatch Advisors's Juno Therapeutics, Inc. position peaked at $29.2M in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Wasatch Advisors's 13F filing for Q1 2018, filed 2 May 2018.